UNSPSC 51152008: Dimethyltubocurarine or metocurine

This classification denotes a muscle relaxant with the molecular formula C40H48N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V0M92G2U26. As of Q4 2014, METOCURINE remains the US FDA Preferred Term for this commodity. Metocurine bears US NLM identifiers UMLS ID C0066465 and NCI Concept Code C76069. SMILES: C[N+]1(CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC(=C(C=C7)OC)O3)[N+](CCC6=CC(=C5OC)OC)(C)C)OC)C.

UNSPSC 51152008 Dimethyltubocurarine or metocurine is a Commodity code that in recent state and local procurement activity encompasses naloxone, safe drug deactivation systems, and generic multi-source pharmaceuticals and OTC products supplied through authorized wholesaler networks to health departments, county health systems, and state cooperative purchasing alliances. State and local governments procure these items to support community health initiatives, emergency response programs, and broad pharmaceutical distribution across multiple facilities and jurisdictions. Issuing bodies include county health departments, state departments of administration managing cooperative purchasing vehicles, and multistate alliances coordinating pharmaceutical procurement across members.

Recent activity centers on Florida and Minnesota. Seminole County, Florida issued an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) in January 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota, Oregon, and other participating jurisdictions, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The MMCAP procurement requires vendors to supply products through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health 110 and 112, and Morris & Dickson), maintain cGMP and DSCSA compliance, and accept a 3 percent administrative fee, with pricing weighted at 75 percent of evaluation scoring.